Download full-text PDF |
Source |
---|
Gan To Kagaku Ryoho
February 2025
Dept. of Surgery, Kansai Rosai Hospital.
Introduction: Robotic liver resection(RLR)has been covered by insurance since 2022. We report our short-term outcomes of RLR performed in Kansai Rosai Hospital.
Patients And Method: Between May 2022 and November 2023, 35 patients underwent RLR.
ANZ J Surg
March 2025
Department of Surgery, University of Notre Dame Australia, Sydney, New South Wales, Australia.
Background: Gastroesophageal reflux disease (GORD) is a significant problem after laparoscopic sleeve gastrectomy (SG). This study aimed to assess the long-term effect of SG with an anterior fundoplication on GORD symptoms.
Methods: A single-centre cohort study of all patients who underwent SG with anterior hemifundoplication (SGAF), with a 2:1 SG only comparison group.
Surg Endosc
March 2025
Department of General Surgery, Affiliated Hospital of Qingdao University, 16# Jiangsu Road, Qingdao, 266000, Shandong Province, People's Republic of China.
Background: Although neoadjuvant therapy (NAT) for advanced gastric cancer (AGC) can benefit patient survival, few studies have compared the short- and long-term outcomes of robotic and laparoscopic gastrectomy for AGC after NAT.
Methods: The clinical data of 321 AGC patients who received NATs and who underwent robotic gastrectomy (RG, n = 109) or laparoscopic gastrectomy (LG, n = 212) between May 2017 and September 2022 were collected and analyzed retrospectively at our center. After propensity score matching (PSM) for 1:1 matching to eliminate bias, both groups had 106 cases.
Indian J Nucl Med
January 2025
Department of Surgical Oncology, Shaukat Khanum Hospital and Trust, Peshawar, Pakistan.
Background: Accurate staging of tumors is paramount in the management of cancer patients. Current noninvasive modalities like computed tomography (CT) and fluorodeoxyglucose positron emission tomography (FDG PET) scan offer viable approaches to stage the disease; however, the role of FDG PET-CT in gastric cancer remains unclear, in comparison to esophageal and gastroesophageal junction cancers, where they have proven usefulness.
Aim: The primary outcome was to assess the usefulness of FDG PET-CT in staging gastric cancer in our population.
Obes Surg
March 2025
Erasmus MC, Rotterdam, Netherlands.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!